Articles from ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the first vault-free ZAP-X® Gyroscopic Radiosurgery® platform in Taiwan will be installed at Kaohsiung Show Chwan Memorial Hospital (KSCH). This marks a significant milestone in the region’s adoption of cutting-edge stereotactic radiosurgery (SRS) technology. Installation is set to begin in Q4 2025, with patient treatments expected to commence in Q1 2026.

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the ZAP-Axon® Radiosurgery Planning System*, an entirely new software platform dedicated to the company’s ZAP-X® Gyroscopic Radiosurgery® system. Designed to simplify, accelerate, and enhance treatment planning, Axon aims to set new benchmarks in world-class radiosurgery brain tumor treatments. Axon is currently pending FDA 510(k) clearance and is expected to be available in Spring 2025.

ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the successful closing of a $78 million Series E funding round led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new financing will advance the commercialization of the Company’s pioneering ZAP-X® Gyroscopic Radiosurgery® platform.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that IMS Shin-Matsudo Central General Hospital, located in the heart of Shinmatsudo, Chiba, Japan, recently completed its inaugural patient treatment utilizing the cutting-edge ZAP-X® Gyroscopic Radiosurgery® platform.

ZAP Surgical Systems, Inc., a global leader in surgical robotics, proudly announces the completion of first patient treatments at Dongguk University Ilsan Hospital using the ZAP-X® Gyroscopic Radiosurgery® platform. This marks the second installation of the ZAP-X system in Korea, signifying a substantial advancement in providing cutting-edge medical care to patients in the Asia-Pacific region.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Apollo Hospital in New Delhi, India, completed its first patient treatment using the new ZAP-X® Gyroscopic Radiosurgery® platform. Following the recent announcement of a strategic partnership and multi-system ZAP-X system order, this first patient treatment marks a significant milestone in the partnership between ZAP Surgical and Apollo Hospitals Enterprise Ltd. As part of the collaboration, the ZAP-X site in New Delhi will also become the regional reference site for customer training and site visits.

ZAP Surgical Systems, Inc., a pioneer and leading innovator in the field of surgical robotics, today announced that Neurosciences and Spine Group (NSG) in Vestal, New York, will soon offer ZAP-X® Gyroscopic Radiosurgery®, the latest advance in non-invasive, non-surgical treatment for brain tumors and other cranial conditions. NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania. System installation is expected to begin in July, with first patient treatments estimated to commence before the end of the year.

In a groundbreaking development for brain tumor care in Poland, the Neurosurgery Centre at N. Copernicus Hospital in Gdansk is thrilled to announce the imminent installation of the ZAP-X® Gyroscopic Radiosurgery® platform. This state-of-the-art system, marking the second of its kind in Poland, is set to redefine the landscape of non-invasive treatment for brain cancers and other neurosurgical conditions.

Westchester Medical Center, the flagship academic medical center for the Westchester Medical Center Health Network (WMCHealth), is set to become the first hospital in New York State to introduce the non-invasive surgical robotics platform, the ZAP-X® Gyroscopic Radiosurgery®, which will transform brain cancer treatments for patients throughout the Hudson Valley. Installation of the ZAP-X platform is expected to commence in mid-2024.

ZAP Surgical, a leading innovator in the field of surgical robotics, today announced that Mercurius Health has entered into a master purchase agreement for five ZAP-X® Gyroscopic Radiosurgery® systems. Through this agreement, ZAP looks to expand its rapidly growing European installed base with added presence across multiple countries in the region.

ZAP Surgical, a leading innovator in the field of surgical robotics, today announced installation of its groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at the Nordstrahl Radiation Therapy group practice at the Nuremberg Nord Clinic. First patient treatments at the site are planned to commence in the winter of 2024. This site marks the 3rd installation in Germany since the ZAP-X received its European Union CE Mark in 2021.

ZAP Surgical, a leading innovator in the field of surgical robotics, today announced the first patient treatment using the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform at Kamiyacho Neurosurgical Clinic in Tokyo, Japan. The event took place on October 19th, marking a significant milestone in the field of neurosurgical care and cancer treatment. Kamiyacho Neurosurgical Clinic, located on the 2nd floor of the Tokyo World Gate Tower, is the second healthcare facility in Japan to introduce the ZAP-X platform.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, has achieved significant legal victories in its ongoing patent litigation against its much larger competitor, Elekta, solidifying the continued availability of the groundbreaking ZAP-X® Gyroscopic Radiosurgery® platform in global markets.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Hacettepe University Hospital in Ankara, Turkey is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform before the end of the year. Patient treatments are expected to begin in early 2024.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that the company received National Medical Products Administration (NMPA) approval in China for its ZAP-X® Gyroscopic Radiosurgery® platform.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Dankook University Hospital (DKUH) in Cheonan, South Korea, is slated to install the novel ZAP-X® Gyroscopic Radiosurgery® platform.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X® Gyroscopic Radiosurgery® platform. CCPSC is the first in France to offer ZAP-X and is part of the renowned American Hospital of Paris, known for offering the most innovative technologies and most advanced treatment methods. CCPSC treated three patients on their first day, each with a single brain metastasis.

ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that the 1,000th patient has been treated with the company’s pioneering ZAP-X® Gyroscopic Radiosurgery® platform. By reducing the cost and complexities of historical stereotactic radiosurgery (SRS) technologies, ZAP has shown rapid success in bringing advanced brain tumor care to settings and locations previously considered infeasible.

ZAP Surgical Systems, Inc. today announced that the company received regulatory approval in India for its first ZAP-X® Gyroscopic Radiosurgery® platform in the form of a No Objection Certificate (NOC) from the Atomic Energy Regulatory Board (AERB).

ZAP Surgical Systems, Inc. today announced that the University Hospital in Olsztyn, in collaboration with the University of Warmia and Mazury in Olsztyn, will become the first center in Poland and Eastern Europe to offer completely non-invasive brain tumor treatments with the ZAP-X® Gyroscopic Radiosurgery® platform. System installation has commenced, and first patient treatments are planned to begin in early 2023.

ZAP Surgical Systems, Inc. today announced that the Institut du Cancer Courlancy (ICC) in Reims, France will add the latest advancement in non-invasive brain tumor treatments, the ZAP-X® Gyroscopic Radiosurgery® platform, to its current portfolio of cancer treatment technologies.

ZAP Surgical Systems, Inc. today announced that Denver-based Neurosurgery One became the first provider in the Rocky Mountain region to treat patients using the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP-X is the latest advancement in completely non-invasive brain tumor treatment and aims to set new standards in patient safety, comfort, convenience, and treatment accuracy. Neurosurgery One doctors are now performing stereotactic radiosurgery (SRS) using ZAP-X in an outpatient facility in the south Denver metro area of Littleton, Colorado.

ZAP Surgical Systems, Inc., developer and manufacturer of the ZAP-X® surgical robot for non-invasive ablation of brain tumors, today announced that the Chairman of Foxconn Technology Co Ltd, Lu Jun-Fu (Stanley Lu), has joined the ZAP Surgical Board of Directors.

ZAP Surgical Systems, Inc. today announced that Dr. John R. Adler, CEO of ZAP and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University received the esteemed Janeway Medal at the annual American Radium Society (ARS) meeting in Scottsdale, Arizona. In addition to receiving the medal, Dr. Adler also delivered the Janeway Lecture entitled “Sometimes an Entrepreneur, Always a Doctor” to the meeting’s clinical delegation.

ZAP Surgical Systems, Inc. today announced that Baptist Health South Florida, will acquire the ZAP-X® Gyroscopic Radiosurgery® platform for cranial stereotactic radiosurgery (SRS). The ZAP-X will be used by Miami Neuroscience Institute, in collaboration with Miami Cancer Institute, both part of Baptist Health South Florida, dedicated to offering the most innovative and advanced techniques to diagnose and treat brain disorders and tumors. Installation of the ZAP-X platform is expected to commence in late 2022.

ZAP Surgical Systems, Inc. today announced that Unicancer, a leading academic promoter of oncology clinical trials and medical equipment purchasing health cooperation group for 19 French comprehensive cancer centers, has selected the ZAP-X® Gyroscopic Radiosurgery® platform for cranial stereotactic radiosurgery. Carefully chosen by domain experts including neurosurgeons, radiation oncologists, and medical physicists, Unicancer awarded ZAP-X as technology-of-choice for their member institutions.

ZAP Surgical Systems, Inc. today announced installation of its first ZAP-X® Gyroscopic Radiosurgery® platform in Japan. Using a new vault-free design that typically eliminates the need for costly shielded radiation treatment rooms, the new ZAP-X is located at the newly redeveloped Utsunomiya bullet train station in Japan’s Tochigi Prefecture. Operated by the Utsunomiya Neurospine Center Symphony Hospital, the site will offer non-invasive outpatient treatments for many brain tumors that historically required invasive surgical procedures.

ZAP Surgical Systems, Inc., maker of the ZAP-X® Gyroscopic Radiosurgery® platform, today announced the appointment of Jie Sun, PhD, as Vice President, Greater China, and Calvin Gao as China General Manager. Prior to NMPA (National Medical Products Administration) regulatory clearance, Mr. Sun and Mr. Gao will pave the way for the commercialization and adoption of ZAP-X for novel and non-invasive brain tumor treatments in China.

ZAP Surgical Systems, Inc. today announced an agreement to bring its advanced ZAP-X® Gyroscopic Radiosurgery® platform to the Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France. As part of the renown American Hospital of Paris, CCPSC will be the first in France to offer the latest advance in radiosurgical brain tumor treatments. First patient treatments with ZAP-X at CCPSC are estimated to begin the Fall of 2022.

ZAP Surgical Systems, Inc. today announced the imminent installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at the Swiss Neuro Radiosurgery Center (SNRC), an organization within the Swiss Clinical Neuroscience Institute (SCNSI) in Zurich, Switzerland.

ZAP Surgical Systems, Inc. today announced the upcoming installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at the European CyberKnife® Center in Munich, Germany. Having recently received CE-clearance for clinical use in Europe, the installation will be among the first ZAP-X systems in the world. Considered as one of the most accomplished global stereotactic radiosurgery (SRS) providers, the European CyberKnife Center plans to initiate ZAP-X patient treatments in summer 2021.